A gap in R&D investments among of pharmaceutical companies is going extreme

While some pharmaceutical companies have spent over 20% of their sales in investments for R&D to generate future sales, there are also pharmaceutical companies invest the formal amount of money, which are less than 1% of sales.

According to the YakupDotCom’s analysis result of quarterly reports announced by KOSPI and KOSDAQ listed pharmaceutical companies in 2015, the average proportion of R&D...